Aldosterone synthase inhibitors

A compound of the formula I

• wherein:
• R1 is selected from —C(O)NH2, —C(O)NH(CH3) and —CN;
• R2 is —(X)—R4, wherein
• —(X)— is a bond, —CH2—, or —O—;
• and
• R4 is selected from
• —H;
• C1-3alkyl, optionally substituted with one to four groups selected from —F and —OH;
• halogen;
• —CN;
• —SO2C1-3alkyl;
• —C(O)N(C1-3alkyl)2, provided —(X)— is not —O—;
• —NHC(O)R5 or —N(CH3)C(O)R5, provided that —(X)— is —CH2— and wherein R5 is selected from C3-6cycloalkyl and C1-3alkyl optionally substituted with one to three —F groups;
• —NHSO2C1-3alkyl;
• —CH(cyclopropyl)NHSO2C1-3alkyl;
• —OCH2C(O)N(C1-3alkyl)2, provided that —(X)— is —CH2—;
• —S(═O)(═NH)CH3, provided that —(X)— is —CH2—;
• heterocyclyl selected from tetrahydropyranyl, tetrahydrofuranyl, pyrrolidinyl, 1,1-dioxo[1,2]-thiazine, morpholinyl, oxazolidinyl, piperidinyl, azetidinyl, wherein said heterocyclyl is optionally substituted with one to three groups selected from —C(O)C1-3alkyl, halogen, —OH, oxo and C1-3alkyl;
• —C(O)-heterocyclyl, provided that —(X)— is —CH2, wherein said heterocyclyl is selected from morpholin-4-yl, pyrrolidin-1-yl and piperidin-1-yl, optionally substituted with one or two groups selected from —F and —OH;
• C3-6cycloalkyl optionally substituted with —CN or —OH;
• and
• phenyl, optionally substituted with —SO2NH2;
• and
• R3 is H, or C1-3alkyl optionally substituted with —OH;
• or
• R2 and R3 together form an annelated five-membered cycloalkyl ring optionally substituted with —OH;
• or a salt or a stereoisomer thereof.